Tetsuya Hosaka

15PUBLICATIONS
8CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 21, 2026
On-treatment viral factors affect subsequent hepatitis B surface antigen seroclearance in patients treated with nucleos(t)ide analogs for > 10 years.

|May 03, 2025
Peripheral blood CD4+/CD8+ T cell ratio may have potential for predicting the treatment response of durvalumab plus tremelimumab therapy (STRIDE) for unresectable hepatocellular carcinoma: Preliminary report.

Yusuke Kawamura, Norio Akuta, Junichi Shindoh

|Sep 26, 2024
Newly established borderline resectable 1 (BR1) category is one of the favorable candidates for selecting the use of multidisciplinary combination therapy in patients with advanced hepatocellular carcinoma treated with systemic therapy.

Yusuke Kawamura, Norio Akuta, Junichi Shindoh

|Dec 19, 2023
A new imaging classification for safer radial access visceral intervention of the liver and optimal case selection: A preliminary report.

Yusuke Kawamura, Norio Akuta, Shunichiro Fujiyama

|Sep 16, 2023
Impact of genetic polymorphism on personalized diet and exercise program for steatotic liver disease.

Norio Akuta, Yusuke Kawamura, Shunichiro Fujiyama

|Mar 09, 2023
Treatment efficacy of diet and exercise program for fatty liver and pretreatment predictors.

Norio Akuta, Yusuke Kawamura, Shunichiro Fujiyama

Pageof 3

Frequent Collaborators

10 joint publications

Norio Akuta

9 joint publications

Yusuke Kawamura

4 joint publications

Shunichirou Fujiyama

3 joint publications

Hitomi Sezaki